Overview

  • Product name
    DAMGO
  • Description
    Potent and selective μ opioid receptor agonist
  • Biological description
    Potent and selective μ opioid receptor agonist (Ki values are 2.0, >1000 and >1000 nM for opioid receptor subtypes μ, κ and δ, respectively). Partial central activity following systemic administration. Antinociceptive.
  • Purity
    > 95%

Properties

References

This product has been referenced in:
  • Lowery JJ  et al. Glycosylation improves the central effects of DAMGO. Chem Biol Drug Des 69:41-7 (2007). Read more (PubMed: 17313456) »
  • Shin MS & Helmstetter FJ Antinociception following application of DAMGO to the basolateral amygdala results from a direct interaction of DAMGO with Mu opioid receptors in the amygdala. Brain Res 1064:56-65 (2005). Read more (PubMed: 16289487) »
  • Raynor K  et al. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45:330-4 (1994). Read more (PubMed: 8114680) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120674.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up